1m61 Citations

Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem.

Biochemistry 41 14176-84 (2002)
Cited: 31 times
EuropePMC logo PMID: 12450381

Abstract

The protein kinase ZAP-70 is involved in T-cell activation, and interacts with tyrosine-phosphorylated peptide sequences known as immunoreceptor tyrosine activation motifs (ITAMs), which are present in three of the subunits of the T-cell receptor. We have studied the tandem SH2 (tSH2) domains of ZAP-70, by both X-ray and NMR. Here, we present the crystal structure of the apoprotein, i.e., the tSH2 domain in the absence of ITAM. Comparison with the previously reported complex structure reveals that binding to the ITAM peptide induces surprisingly large movements between the two SH2 domains and within the actual binding sites. The conformation of the ITAM-free protein is partly governed by a hydrophobic cluster between the linker region and the C-terminal SH2 domain. Our data suggest that the two SH2 domains are able to undergo large interdomain movements. The proposed relative flexibility of the SH2 domains is further supported by the finding that no NMR signals could be detected for the two helices connecting the SH2 domains; these are likely to be broadened beyond detection due to conformational exchange. It is likely that this conformational reorientation induced by ITAM binding is the main signaling event activating the kinase domain in ZAP-70. Another NMR observation was that the N-terminal SH2 domain could bind tetrapeptides derived from the ITAM sequence, apparently without the need to interact with the C-terminal domain. In contrast, the C-terminal domain has little affinity for tetrapeptides. The opposite situation is true for binding to plain phosphotyrosine, where the C-terminal domain has a higher affinity. Distinct features in the crystal structure, showing the interdependence of both domains, explain these binding data.

Articles - 1m61 mentioned but not cited (7)

  1. DockoMatic 2.0: high throughput inverse virtual screening and homology modeling. Bullock C, Cornia N, Jacob R, Remm A, Peavey T, Weekes K, Mallory C, Oxford JT, McDougal OM, Andersen TL. J Chem Inf Model 53 2161-2170 (2013)
  2. Molecular mechanism of selective recruitment of Syk kinases by the membrane antigen-receptor complex. Bond PJ, Faraldo-Gómez JD. J Biol Chem 286 25872-25881 (2011)
  3. Computational approach to identify enzymes that are potential therapeutic candidates for psoriasis. Park D, Jeong HO, Kim BC, Ha YM, Young Chung H. Enzyme Res 2011 826784 (2011)
  4. Differences in the dynamics of the tandem-SH2 modules of the Syk and ZAP-70 tyrosine kinases. Hobbs HT, Shah NH, Badroos JM, Gee CL, Marqusee S, Kuriyan J. Protein Sci 30 2373-2384 (2021)
  5. Analysis of Phosphorylation-dependent Protein Interactions of Adhesion and Degranulation Promoting Adaptor Protein (ADAP) Reveals Novel Interaction Partners Required for Chemokine-directed T cell Migration. Kuropka B, Witte A, Sticht J, Waldt N, Majkut P, Hackenberger CP, Schraven B, Krause E, Kliche S, Freund C. Mol Cell Proteomics 14 2961-2972 (2015)
  6. An evolutionary divergent thermodynamic brake in ZAP-70 fine-tunes the kinetic proofreading in T cells. Gangopadhyay K, Roy A, Chandradasan AC, Roy S, Debnath O, SenGupta S, Chowdhury S, Das D, Das R. J Biol Chem 298 102376 (2022)
  7. PON-SC - program for identifying steric clashes caused by amino acid substitutions. Čalyševa J, Vihinen M. BMC Bioinformatics 18 531 (2017)


Reviews citing this publication (9)

  1. Tec family kinases in T lymphocyte development and function. Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL. Annu Rev Immunol 23 549-600 (2005)
  2. ZAP-70: an essential kinase in T-cell signaling. Wang H, Kadlecek TA, Au-Yeung BB, Goodfellow HE, Hsu LY, Freedman TS, Weiss A. Cold Spring Harb Perspect Biol 2 a002279 (2010)
  3. The Src, Syk, and Tec family kinases: distinct types of molecular switches. Bradshaw JM. Cell Signal 22 1175-1184 (2010)
  4. The structure, regulation, and function of ZAP-70. Au-Yeung BB, Deindl S, Hsu LY, Palacios EH, Levin SE, Kuriyan J, Weiss A. Immunol Rev 228 41-57 (2009)
  5. ZAP-70 in Signaling, Biology, and Disease. Au-Yeung BB, Shah NH, Shen L, Weiss A. Annu Rev Immunol 36 127-156 (2018)
  6. Therapeutic prospect of Syk inhibitors. Ruzza P, Biondi B, Calderan A. Expert Opin Ther Pat 19 1361-1376 (2009)
  7. The target discovery process. Egner U, Krätzschmar J, Kreft B, Pohlenz HD, Schneider M. Chembiochem 6 468-479 (2005)
  8. Insight into the therapeutic aspects of 'Zeta-Chain Associated Protein Kinase 70 kDa' inhibitors: a review. Kaur M, Singh M, Silakari O. Cell Signal 26 2481-2492 (2014)
  9. Regulating the discriminatory response to antigen by T-cell receptor. Gangopadhyay K, Roy S, Sen Gupta S, Chandradasan AC, Chowdhury S, Das R. Biosci Rep 42 BSR20212012 (2022)

Articles citing this publication (15)

  1. Structural basis for the inhibition of tyrosine kinase activity of ZAP-70. Deindl S, Kadlecek TA, Brdicka T, Cao X, Weiss A, Kuriyan J. Cell 129 735-746 (2007)
  2. Structural basis for activation of ZAP-70 by phosphorylation of the SH2-kinase linker. Yan Q, Barros T, Visperas PR, Deindl S, Kadlecek TA, Weiss A, Kuriyan J. Mol Cell Biol 33 2188-2201 (2013)
  3. Structural and biophysical characterization of the Syk activation switch. Grädler U, Schwarz D, Dresing V, Musil D, Bomke J, Frech M, Greiner H, Jäkel S, Rysiok T, Müller-Pompalla D, Wegener A. J Mol Biol 425 309-333 (2013)
  4. Tyr130 phosphorylation triggers Syk release from antigen receptor by long-distance conformational uncoupling. Zhang Y, Oh H, Burton RA, Burgner JW, Geahlen RL, Post CB. Proc Natl Acad Sci U S A 105 11760-11765 (2008)
  5. Genome wide analysis of pathogenic SH2 domain mutations. Lappalainen I, Thusberg J, Shen B, Vihinen M. Proteins 72 779-792 (2008)
  6. Novel mechanism of interaction of p85 subunit of phosphatidylinositol 3-kinase and ErbB3 receptor-derived phosphotyrosyl peptides. Suenaga A, Takada N, Hatakeyama M, Ichikawa M, Yu X, Tomii K, Okimoto N, Futatsugi N, Narumi T, Shirouzu M, Yokoyama S, Konagaya A, Taiji M. J Biol Chem 280 1321-1326 (2005)
  7. Non-degradative Ubiquitination of Protein Kinases. Ball KA, Johnson JR, Lewinski MK, Guatelli J, Verschueren E, Krogan NJ, Jacobson MP. PLoS Comput Biol 12 e1004898 (2016)
  8. 3D structure of Syk kinase determined by single-particle electron microscopy. Arias-Palomo E, Recuero-Checa MA, Bustelo XR, Llorca O. Biochim Biophys Acta 1774 1493-1499 (2007)
  9. Protein flexibility and ligand rigidity: a thermodynamic and kinetic study of ITAM-based ligand binding to Syk tandem SH2. de Mol NJ, Catalina MI, Dekker FJ, Fischer MJ, Heck AJ, Liskamp RM. Chembiochem 6 2261-2270 (2005)
  10. Conformational rearrangements upon Syk auto-phosphorylation. Arias-Palomo E, Recuero-Checa MA, Bustelo XR, Llorca O. Biochim Biophys Acta 1794 1211-1217 (2009)
  11. Binding of a diphosphorylated-ITAM peptide to spleen tyrosine kinase (Syk) induces distal conformational changes: a hydrogen exchange mass spectrometry study. Catalina MI, Fischer MJ, Dekker FJ, Liskamp RM, Heck AJ. J Am Soc Mass Spectrom 16 1039-1051 (2005)
  12. Modification by covalent reaction or oxidation of cysteine residues in the tandem-SH2 domains of ZAP-70 and Syk can block phosphopeptide binding. Visperas PR, Winger JA, Horton TM, Shah NH, Aum DJ, Tao A, Barros T, Yan Q, Wilson CG, Arkin MR, Weiss A, Kuriyan J. Biochem J 465 149-161 (2015)
  13. Switching between low and high affinity for the Syk tandem SH2 domain by irradiation of azobenzene containing ITAM peptidomimetics. Kuil J, van Wandelen LT, de Mol NJ, Liskamp RM. J Pept Sci 15 685-691 (2009)
  14. Identification of Inhibitors of the Association of ZAP-70 with the T Cell Receptor by High-Throughput Screen. Visperas PR, Wilson CG, Winger JA, Yan Q, Lin K, Arkin MR, Weiss A, Kuriyan J. SLAS Discov 22 324-331 (2017)
  15. Dephosphorylation accelerates the dissociation of ZAP70 from the T cell receptor. Goyette J, Depoil D, Yang Z, Isaacson SA, Allard J, van der Merwe PA, Gaus K, Dustin ML, Dushek O. Proc Natl Acad Sci U S A 119 e2116815119 (2022)